BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
PHASE2
This is a single-center, single-arm, phase II study, aiming to preliminaril...
An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
PHASE2
An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating ...